REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/07/2026
Back to search
Official data from USPTO
CUMBERLAND PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CUMBERLAND PHARMACEUTICALS
ST13
US500000078647122Class
5
Filing
78647122
Registration
3274306
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/07/2026
Trademark type
Word
Nice classes
5
Filing date
06/09/2005
Registration date
08/07/2007
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/12/2017
Last transaction
08/07/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/09/2003
First use in commerce
2004-05-00
Drawing code
4
Owner type
03
Owner location
Nashville, TN, US
Examiner
WHITTAKER BROWN, TRACY
Law office
M20
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Cumberland Pharmaceuticals Inc.
Representatives
Kristina Montanaro Schrader Adams and Reese LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the treatment of critical care and hospital emergency patientsanalgesicsantipyreticsantidotesin the treatment of gastrointestinal illnesses
Publications
History of USPTO decisions and trademark events.
38 publications found
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/16/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/16/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/16/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/16/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/16/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/22/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/22/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/22/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/12/2017
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/12/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/12/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/12/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
06/06/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/07/2016
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/29/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/29/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/29/2013
E815
TEAS SECTION 8 & 15 RECEIVED
06/17/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/29/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
08/07/2007
PUBO
PUBLISHED FOR OPPOSITION
05/22/2007
NPUB
NOTICE OF PUBLICATION
05/02/2007
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/28/2007
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/28/2007
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/30/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/30/2007
ALIE
ASSIGNED TO LIE
01/30/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/03/2007
GNRT
NON-FINAL ACTION E-MAILED
07/18/2006
CNRT
NON-FINAL ACTION WRITTEN
07/18/2006
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2006
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/13/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/13/2006
GNRT
NON-FINAL ACTION E-MAILED
12/29/2005
CNRT
NON-FINAL ACTION WRITTEN
12/29/2005
DOCK
ASSIGNED TO EXAMINER
12/29/2005
NWAP
NEW APPLICATION ENTERED
06/14/2005
Continuous trademark protection
Get notified about every new filing that threatens CUMBERLAND PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.